Synergic neurotoxic and paraneoplastic neurological syndrome during cysplatin chemotherapy in case of transplanted experimental rat lymphoma

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The aim of the study is assessment of combined effect of homotransplanted rat lymphoma (Pliss’ Lymphosrcoma) growth and antitumor therapy (cysplatin) upon the functioning of the nervous system was accomplished in 160 male Wistar rats, divided into four groups: intact animals, rats treated with cysplatin, rats with transplanted lymphoma, and rats with transplanted lymphoma that received cysplatin treatment. The neurologic deficiency degree as well as basic myelin protein peripheral blood level (nervous system impairment hematological marker) were comparatively assessed. Tumor development was accompanied with emergence and subsequent growth of neurologic deficit in locomotory, sensory and coordinative spheres as well as pronounced growth of basic myeline protein plasma level thus making this model a valid test-system for studying paraneoplastic neurologic syndrome. Cysplatin has produced a non-selective toxic effect upon the nervous system of the experimental animals within its therapeutic window range documented by neurotoxic syndrome. Subsequently along with elimination of cysplatin and its derivates from the organism, systemic neurotoxic effect intensity decreased and the nervous system functional state parameters returned to control values. Using cysplatin for the treatment of homotransplanted experimental rat lymphoma results in synergic neurotoxic and paraneoplastic neurological syndrome through combined injury of the nervous system.

Full Text

Restricted Access

About the authors

Tamara D. Gagloeva

B.P. Konstantinov St. Petersburg Institute of Nuclear Physics of the National Research Center “Kurchatov Institute”; National Research Center “Kurchatov Institute”

Email: gagloeva_td@pnpi.nrcki.ru
SPIN-code: 1056-5503

Junior Research Associate, Center of Preclinical and Clinical Research; Junior Research Associate, Neorocognitive Research Resource Center

Russian Federation, Leningrad Region, Gatchina; Moscow

Alexander P. Trashkov

B.P. Konstantinov St. Petersburg Institute of Nuclear Physics of the National Research Center “Kurchatov Institute”; National Research Center “Kurchatov Institute”

Author for correspondence.
Email: trashkov_ap@pnpi.nrcki.ru
SPIN-code: 4231-1258

MD, PhD, Head, Center of Preclinical and Clinical Research

Russian Federation, Leningrad Region, Gatchina; Moscow

Alexander I. Budko

B.P. Konstantinov St. Petersburg Institute of Nuclear Physics of the National Research Center “Kurchatov Institute”

Email: budko_ai@pnpi.nrcki.ru

MD, PhD, Laboratory Researcher, Center of Preclinical and Clinical Research

Russian Federation, Leningrad Region, Gatchina

Yuliya A. Levkova

B.P. Konstantinov St. Petersburg Institute of Nuclear Physics of the National Research Center “Kurchatov Institute”

Email: levkova_ja@pnpi.nrcki.ru

Laboratory Researcher, Center of Preclinical and Clinical Research

Russian Federation, Leningrad Region, Gatchina

Andrey N. Petrovskiy

B.P. Konstantinov St. Petersburg Institute of Nuclear Physics of the National Research Center “Kurchatov Institute”

Email: petrovskiy_an@pnpi.nrcki.ru

MD, PhD, Senior Research Associate, Center of Preclinical and Clinical Research

Russian Federation, Leningrad Region, Gatchina

Anton B. Cherepov

National Research Center “Kurchatov Institute”

Email: cherepov_ab@nrcki.ru

Leading Engeneer, Resourse Center of Neurocognitive Technologies

Russian Federation, Moscow

Nikolay V. Tsygan

B.P. Konstantinov St. Petersburg Institute of Nuclear Physics of the National Research Center “Kurchatov Institute”; Kirov Military Medical Academy

Email: tsygan_nv@pnpi.nrcki.ru

MD, PhD, Dr. Sci. (Med.), Assistant Professor, Leading Research Associate, Center of Preclinical and Clinical Research; Vice-Head, Department of the Nervous Diseases

Russian Federation, Leningrad Region, Gatchina; Saint Petersburg

Viktor Georgievich Antonov

St. Petersburg State Pediatric Medical University

Email: Mulit7@mail.ru

MD, PhD, Dr. Sci. (Med.), Professor, Professor of the Department of Biological Chemistry

Russian Federation, Saint Petersburg

Mariya A. Pahomova

St. Petersburg State Pediatric Medical University

Email: mariya.pahomova@mail.ru

Senior Research Associate, Research Center

Russian Federation, Saint Petersburg

References

  1. Vasil’ev AG, Komyakov BK, Tagirov NS, Musaev SA. Percutaneous nephrolithitripsy in the treatment of coral calculus nephrolithiasis. Herald of North-Western State Medical University named after I.I. Mechnikov. 2009;(4(33)):183–186 (In Russ.)
  2. Guidelines for the maintenance and use of laboratory animals. 8th edition. Belozercevoj IV, Blinova DV, Krasil’shchikovoj MS, eds. Moscow: IRBIS; 2017. 336 p. (In Russ.)
  3. Sostojanie onkologicheskoj pomoshhi naseleniju Rossii v 2021 godu. Kaprin AD, Starinskiy VV, Shahzadova AO, eds. Moscow: MNIOI im. P.A. Gercena — filial FGBU “NMIC radiologii” Minzdrava Rossii; 2022. 239 p. (In Russ.)
  4. Tagirov NS, Nazarov TH, Vasil’ev AG, et al. The experience of using percutaneous nephrolithotripsy and contact ureterolithotripsy in the complex treatment of urolithiasis. Preventive and Clinical Medicine. 2012;(4(45)):30–33. (In Russ.)
  5. Trashkov AP, Brus TV, Vasil’ev AG, Artemenko MR. Biochemical profile of rats with non-alcoholic fatty liver disease of various gravity and its correction with Remaxol. Pediatrician (St. Petersburg). 2017;8(4):78–85. (In Russ.) doi: 10.17816/PED8478–85
  6. Trashkov AP, Vasil’ev AG, Kovalenko AL, Tagirov NS. Metabolic therapy of nephrolithiasis in two different rat models of kidney disease. Experimental and Clinical Pharmacology. 2015;78(3):17–21. (In Russ.)
  7. Trashkov AP, Vasil’ev AG, Cygan NV, et al. Antithrombotic therapy in oncology: contemporary concepts and pending problems. Pediatrician (St. Petersburg). 2012;3(2):3–19. (In Russ.)
  8. Trashkov AP, Panchenko AV, Kayukova ES, et al. Lejkemija P-388 u myshej linii CDF1 kak test-sistema opuhol-associirovannogo neoangiogeneza i giperkoaguljacii. Byulleten Eksperimental’noj Biologii i Mediciny. 2014;158(10):500–502. (In Russ.)
  9. Hajcev NV, Vasil’ev AG, Trashkov AP, et al. The influence of sex and age upon response of white rats to hypoxic hypoxia. Pediatrician (St. Petersburg). 2015;6(2):71–77. (In Russ.)
  10. Authier N, Gillet JP, Fialip J, et al. An animal model of nociceptive peripheral neuropathy following repeated cisplatin injections. Exp Neurol. 2003;182(1):12–20. doi: 10.1016/s0014-4886(03)00003-7
  11. Bland M. An Introduction to Medical Statistics. 3rd edition. Oxford Medical Publications. 2000. 448 р.
  12. Boyle FM, Wheeler HR, Shenfield GM. Amelioration of experimental cisplatin and paclitaxel neuropathy with glutamate. J Neuro-Oncol. 1999;41(2):107–116. doi: 10.1023/a:1006124917643
  13. Soussain C, Ricard D, Fike JR, et al CNS complications of radiotherapy and chemotherapy. Lanset. 2009;374(9701): 1639–1651. doi: 10.1016/S0140-6736(09)61299-X
  14. Carozzi V, Canta A, Chiorazzi A, Cavaletti G. Chemotherapy-induced peripheral neuropathy: what do we know about mechanisms? Neurosci Lett. 2015;596:90–107. doi: 10.1016/j.neulet.2014.10.014
  15. Dalmau J, Tüzün E, Wu HY, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol. 2007;61(1):25–36. doi: 10.1002/ana.21050
  16. Deber CM, Reynolds SJ. Central nervous system myelin: structure, function, and pathology. Clin Biochem. 1991; 24(2):113–134. doi: 10.1016/0009-9120(91)90421-a
  17. Deber CM, Liu LP, Wang C. Perspective: peptides as mimics of transmembrane segments in proteins. J Pept Res. 1999;54(3)200–205. doi: 10.1034/j.1399-3011.1999.00118.x
  18. Directive 2010/63/EU of the European Parliament and of the Council. Official Journal of the European Union. Retrieved 16 August 2020.
  19. Dropcho EJ, Furneaux H, Chen YT, et al. Expression of the CDR brain protein by tumors from patients with paraneoplastic cerebellar degeneration (Abstract). Ann Neurol. 1988;24:121–2.
  20. Garcia JH, Wagner S, Liu KF, Hu XJ. Neurological deficit and extent of neuronal necrosis attributable to middle cerebral artery occlusion in rats. Statistical validation. Stroke. 1995;26(4):627–634. discussion 635. doi: 10.1161/01.str.26.4.627
  21. Kanikannan MA, Sirisha Y, Uppin MS, et al. Incidence and spectrum of paraneoplastic neurological syndromes: single center study. J Neurooncol. 2015;125(1):197–206. doi: 10.1007/s11060–015–1898–7
  22. Manley GT, Smitt PS, Dalmau J, et al. Hu antigens: Reactivity with hu antibodies, tumor expression, and major immunogenic sites. Ann Neurol. 1995;38(1):102–110. doi: 10.1002/ana.410380117
  23. Panchenko AV, Popovich IG, Egormin PA, et al. Biomarkers of aging, life span and spontaneous carcinogenesis in the wild type and HER-2 transgenic FVB/N female mice. Biogerontology. 2016;17(2):317–324. doi: 10.1007/s10522-015-9611-y
  24. Gregg RW, Molepo JM, Monpetit VJ, et al. Cisplatin neurotoxicity: the relationship between dosage, time, and platinum concentration in neurologic tissues, and morphologic evidence of toxicity. J Clin Oncol. 1992;10(5):795–803. doi: 10.1200/JCO.1992.10.5.795
  25. Sisignano M, Baron R, Scholich K, Geisslinger G. Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain. Nat Rev Neurol. 2014;10(12): 694–707. doi: 10.1038/nrneurol.2014.211
  26. Staff NP, Grisold A, Grisold W, Windebank AJ. Chemotherapy-induced peripheral neuropathy: A current review. Ann Neurol. 2017;81(6):772–781. doi: 10.1002/ana.24951
  27. Tsygan NV, Trashkov AP, Litvinenko IV, et al. Autoimmunity in acute ischemic stroke and the role of blood-brain barrier: the dark side or the light one? Frontiers of Medicine. 2019;13(4):420–426. doi: 10.1007/s11684-019-0688-6
  28. Tzakos AG, Troganis A, Theodorou V, et al. Structure and function of the myelin proteins: current status and perspectives in relation to multiple sclerosis. Curr Med Chem. 2005;12(13):1569–1587. doi: 10.2174/0929867054039026
  29. Wolf S, Barton D, Kottschade L, et al. Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. Eur J Cancer. 2008;44(11): 1507–1515. doi: 10.1016/j.ejca.2008.04.018
  30. Wongtawatchai T, Agthong S, Kaewsema A, Chentanez V. Altered phosphorylation of mitogen-activated protein kinases in dorsal root ganglia and sciatic nerve of rats with cisplatin-induced neuropathy. Asian Biomed (Res Rev News). 2012;6:397–411.

Supplementary files

Supplementary Files
Action
1. Figure. Dynamics of tumor growth and its volume in case of treatment with сysplatine in control points of the study

Download (107KB)
Indexing metadata

Copyright (c) 2023 Eco-Vector


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 69634 от 15.03.2021 г.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies